Literature DB >> 30429375

Dysregulated NK cell PLCγ2 signaling and activity in juvenile dermatomyositis.

Allison A Throm1,2, Joshua B Alinger1, Jeanette T Pingel1, Allyssa L Daugherty1, Lauren M Pachman3,4, Anthony R French1,2.   

Abstract

Juvenile dermatomyositis (JDM) is a debilitating pediatric autoimmune disease manifesting with characteristic rash and muscle weakness. To delineate signaling abnormalities in JDM, mass cytometry was performed with PBMCs from treatment-naive JDM patients and controls. NK cell percentages were lower while frequencies of naive B cells and naive CD4+ T cells were higher in JDM patients than in controls. These cell frequency differences were attenuated with cessation of active disease. A large number of signaling differences were identified in treatment-naive JDM patients compared with controls. Classification models incorporating feature selection demonstrated that differences in phospholipase Cγ2 (PLCγ2) phosphorylation comprised 10 of 12 features (i.e., phosphoprotein in a specific immune cell subset) distinguishing the 2 groups. Because NK cells represented 5 of these 12 features, further studies focused on the PLCγ2 pathway in NK cells, which is responsible for stimulating calcium flux and cytotoxic granule movement. No differences were detected in upstream signaling or total PLCγ2 protein levels. Hypophosphorylation of PLCγ2 and downstream mitogen-activated protein kinase-activated protein kinase 2 were partially attenuated with cessation of active disease. PLCγ2 hypophosphorylation in treatment-naive JDM patients resulted in decreased calcium flux. The identification of dysregulation of PLCγ2 phosphorylation and decreased calcium flux in NK cells provides potential mechanistic insight into JDM pathogenesis.

Entities:  

Keywords:  Autoimmunity; Calcium signaling; Immunology; Innate immunity; Rheumatology

Mesh:

Substances:

Year:  2018        PMID: 30429375      PMCID: PMC6302943          DOI: 10.1172/jci.insight.123236

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  35 in total

1.  Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence.

Authors:  Rita K Bode; Marisa S Klein-Gitelman; Michael L Miller; Toula S Lechman; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2003-02-15

Review 2.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

3.  Decreased levels of CD54 (ICAM-1)-positive lymphocytes in the peripheral blood in untreated patients with active juvenile dermatomyositis.

Authors:  M R O'Gorman; L Bianchi; D Zaas; V Corrochano; L M Pachman
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

4.  Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.

Authors:  Rohit Aggarwal; Andriy Bandos; Ann M Reed; Dana P Ascherman; Richard J Barohn; Brian M Feldman; Frederick W Miller; Lisa G Rider; Michael O Harris-Love; Marc C Levesque; Chester V Oddis
Journal:  Arthritis Rheumatol       Date:  2014-03       Impact factor: 10.995

5.  Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.

Authors:  M L Miller; R Lantner; L M Pachman
Journal:  J Rheumatol       Date:  1983-08       Impact factor: 4.666

6.  Src-family kinases play an essential role in differentiation signaling downstream of macrophage colony-stimulating factor receptors mediating persistent phosphorylation of phospholipase C-gamma2 and MAP kinases ERK1 and ERK2.

Authors:  C Bourgin-Hierle; S Gobert-Gosse; J Thérier; M-F Grasset; G Mouchiroud
Journal:  Leukemia       Date:  2007-11-01       Impact factor: 11.528

7.  Natural killer cell activity in dermatomyositis-polymyositis.

Authors:  R Gonzalez-Amaro; J Alcocer-Varela; D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1987-04       Impact factor: 4.666

8.  Phospholipase C-gamma2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells.

Authors:  Anouk Caraux; Nayoung Kim; Sarah E Bell; Simona Zompi; Thomas Ranson; Sarah Lesjean-Pottier; Marcos E Garcia-Ojeda; Martin Turner; Francesco Colucci
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

9.  Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damage.

Authors:  Helga Sanner; Thomas Schwartz; Berit Flatø; Maria Vistnes; Geir Christensen; Ivar Sjaastad
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

10.  Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders.

Authors:  Frederick W Miller; Robert G Cooper; Jiří Vencovský; Lisa G Rider; Katalin Danko; Lucy R Wedderburn; Ingrid E Lundberg; Lauren M Pachman; Ann M Reed; Steven R Ytterberg; Leonid Padyukov; Albert Selva-O'Callaghan; Timothy R D J Radstake; David A Isenberg; Hector Chinoy; William E R Ollier; Terrance P O'Hanlon; Bo Peng; Annette Lee; Janine A Lamb; Wei Chen; Christopher I Amos; Peter K Gregersen
Journal:  Arthritis Rheum       Date:  2013-12
View more
  6 in total

Review 1.  Advances Toward Precision Medicine in Juvenile Dermatomyositis.

Authors:  Jessica Neely; Susan Kim
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

2.  MECHANISTIC AND DATA-DRIVEN MODELS OF CELL SIGNALING: TOOLS FOR FUNDAMENTAL DISCOVERY AND RATIONAL DESIGN OF THERAPY.

Authors:  Paul J Myers; Sung Hyun Lee; Matthew J Lazzara
Journal:  Curr Opin Syst Biol       Date:  2021-06-09

3.  Multi-Modal Single-Cell Sequencing Identifies Cellular Immunophenotypes Associated With Juvenile Dermatomyositis Disease Activity.

Authors:  Jessica Neely; George Hartoularos; Daniel Bunis; Yang Sun; David Lee; Susan Kim; Chun Jimmie Ye; Marina Sirota
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

4.  Serum protein biomarkers for juvenile dermatomyositis: a pilot study.

Authors:  Shefa M Tawalbeh; Wilfredo Marin; Gabrielle A Morgan; Utkarsh J Dang; Yetrib Hathout; Lauren M Pachman
Journal:  BMC Rheumatol       Date:  2020-10-01

Review 5.  Natural killer cells in inflammatory autoimmune diseases.

Authors:  Yuyan Yang; Jessica Day; Fernando Souza-Fonseca Guimaraes; Ian P Wicks; Cynthia Louis
Journal:  Clin Transl Immunology       Date:  2021-02-01

6.  Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy.

Authors:  Lauren M Pachman; Brian E Nolan; Deidre DeRanieri; Amer M Khojah
Journal:  Curr Treatm Opt Rheumatol       Date:  2021-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.